$BSX · Boston Scientific Corporation
Boston Scientific Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026. The filing includes the company’s consolidated financial statements and accompanying notes for the third quarter and the first nine months of fiscal 2026.
The notes disclose several business acquisitions completed during the nine-month period. These include Penumbra Inc. in January 2026, Nalu Medical in January 2026, Scivita Medical in August 2026, and other smaller acquisitions. The filing also references prior-year acquisitions of SoniVie Ltd., Bolt Medical Inc., and Cortex Inc., which were completed in 2025.
The filing reports standard quarterly financial data and acquisition-related disclosures. No further details on operating results or management discussion are available from the provided excerpt.